Health
Post-Vax Clot Case Supports Angiomax Use – MedPage Today
This might be a good non-heparin alternative, docs say
Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported.
The 40-year-old woman presented with a headache on the same day that the CDC and FDA hit pause on use of the Johnson & Johnson vaccine over risk of what’s being dubbed vaccine-induced thrombotic thrombocytopenia (VITT) or thrombosis with thrombocytopenia syndrome (TTS).
She developed a headache, sinus pressure, myalgias, and sore throat with tonsillar…
-
Noosa News10 hours agoPill checking to resume in Queensland months after government axed funding
-
Noosa News20 hours agoBrisbane nation’s third-youngest capital; Leaders condemn anti-immigration rally
-
General23 hours agoAs Iran-Australia relations plunge to a new low, Tehran faces another diplomatic setback
-
Business12 hours agoBrokers name 3 ASX shares to buy today 29 August 2025